Crossmark Global Holdings Inc. Invests $475,000 in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Crossmark Global Holdings Inc. purchased a new stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,154 shares of the company's stock, valued at approximately $475,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Champlain Investment Partners LLC increased its holdings in shares of Ryan Specialty by 28.0% in the first quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company's stock worth $274,022,000 after buying an additional 1,079,505 shares during the period. Blair William & Co. IL grew its holdings in shares of Ryan Specialty by 3.4% in the second quarter. Blair William & Co. IL now owns 2,866,003 shares of the company's stock valued at $165,970,000 after purchasing an additional 94,663 shares in the last quarter. Bessemer Group Inc. lifted its stake in shares of Ryan Specialty by 33.9% in the 1st quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company's stock valued at $106,886,000 after purchasing an additional 488,067 shares during the last quarter. Principal Financial Group Inc. raised its stake in shares of Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company's stock valued at $56,545,000 after acquiring an additional 509,548 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in shares of Ryan Specialty by 132.2% during the second quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company's stock valued at $48,425,000 after buying an additional 476,126 shares during the period. Institutional investors and hedge funds own 84.82% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on RYAN. Bank of America raised their price target on Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research note on Thursday, October 10th. The Goldman Sachs Group upped their target price on Ryan Specialty from $64.00 to $72.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 9th. Barclays started coverage on Ryan Specialty in a research note on Wednesday, September 4th. They set an "overweight" rating and a $76.00 target price for the company. JPMorgan Chase & Co. lifted their target price on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an "underweight" rating in a research note on Friday, August 2nd. Finally, BMO Capital Markets upgraded Ryan Specialty from a "market perform" rating to an "outperform" rating and upped their target price for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $70.33.

Insiders Place Their Bets

In other news, EVP Mark Stephen Katz sold 14,790 shares of the company's stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares of the company's stock, valued at $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction on Monday, August 19th. The stock was sold at an average price of $64.69, for a total transaction of $2,264,150.00. Following the sale, the director now directly owns 19,251 shares of the company's stock, valued at $1,245,347.19. This represents a 64.51 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 94,193 shares of company stock valued at $6,208,493 over the last 90 days. 11.10% of the stock is currently owned by company insiders.

Ryan Specialty Stock Up 0.0 %

RYAN traded up $0.03 during trading on Friday, hitting $70.94. The company had a trading volume of 456,601 shares, compared to its average volume of 826,846. The company has a market cap of $18.57 billion, a PE ratio of 92.13, a P/E/G ratio of 1.61 and a beta of 0.62. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a 1-year low of $41.49 and a 1-year high of $73.10. The business has a 50-day moving average of $68.28 and a 200-day moving average of $61.90.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.41. The business had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business's revenue for the quarter was up 20.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.32 EPS. As a group, analysts forecast that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th will be given a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a yield of 0.62%. The ex-dividend date is Tuesday, November 12th. Ryan Specialty's payout ratio is 57.14%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.